RxDoctor Payments Data

Timothy Cragun, DO

Dermatology · Nellis Afb, NVNPI 1760419881

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.4% of the total across 470 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations.

$9,630in general payments, 2019–2025

Across 470 payments — averaging $20.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Johnson & Johnson$1K
  • Lilly USA, LLC$997
  • Galderma Laboratories, L.p.$682
  • E.r. Squibb & Sons, L.L.C.$571
  • Sanofi$482
  • plus $4K from 23 others

What the payments were for

  • Food & beverage$9,37997%
  • Education$2513%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,630 in reported general payments places this provider in the 70th percentile of 78 dermatology providers in Nevada.

See all dermatology providers in Nevada

Medicare billing

Part B allowed, 2024
$270,701
Medicare patients
525
Services billed
5,906

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab46$166,414
Taltz AutoinjectorIxekizumab24$163,211
Clobetasol Propionate86$4,571
Fluorouracil47$3,154
Triamcinolone Acetonide97$1,180
Ketoconazole99$1,083
Doxycycline Hyclate34$738
Imiquimod21$503
Doxycycline Monohydrate26$424
Tretinoin11$370
ValacyclovirValacyclovir Hcl34$302
Cephalexin35$295
Hydrocortisone11$133
Terbinafine Hcl14$70

Paid to pharmacies, not to this prescriber.

Other dermatology in Nellis Afb

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →